Susana Mendoza

Ms. Susana Mendoza

Universidade Federal do Rio de janiero UFRJ
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 January 2017 in American Journal of Alzheimer's Disease and Other Dementias®
Verified
Journal Article
Closed access
DMDiana Jennifer Moreno
Diana Jennifer Moreno
SMSusana Mendoza
Susana Mendoza
ÁRÁngela Ríos
Ángela Ríos
FLFrancisco Lopera
Francisco Lopera
HOHenry Ostos
Henry Ostos
GBGabriel Bedoya
Gabriel Bedoya
The association of variants in CLU, CR1, PICALM, BIN1, ABCA7, and CD33 genes with late-onset Alzheimer’s disease (LOAD) was evaluated and confirmed through genome-wide association study. However, it is unknown whether these associations can be replicated in admixed populations. The association of 14 single-nucleotide polymorphisms in those genes was evaluated in 280 LOAD cases and 357 controls from the Colombian population. In a multivariate analysis using age, gender, APOE∊4 status, and admixture covariates, significant associations were obtained (P < .05) for variants in BIN1 (rs744373, odds ratio [OR]: 1.42), CLU (rs11136000, OR: 0.66), PICALM (rs541458, OR: 0.69), ABCA7 (rs3764650, OR: 1.7), and CD33 (rs3865444, OR: 1.12). Likewise, a significant interaction effect was observed between CLU and CR1 variants with APOE. This study replicated the associations previously reported in populations of European ancestry and shows that APOE variants have a regulatory role on the effect that variants in other loci have on LOAD, reflecting the importance of gene–gene interactions in the etiology of neurodegenerative diseases.

28 March 2021 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
SMSusana Mendoza
Susana Mendoza
Daniel Zamith-MirandaDaniel Zamith-Miranda
Daniel Zamith-Miranda
TTTamás Takács
Tamás Takács
AGAttila Gacser
Attila Gacser
Joshua D NosanchukJoshua D Nosanchuk
Joshua D Nosanchuk
AGAllan Guimaraes
Allan Guimaraes
The prevalence of fungal infections has increased in immunocompromised patients, leading to millions of deaths annually. Arachidonic acid (AA) metabolites, such as eicosanoids, play important roles in regulating innate and adaptative immune function, particularly since they can function as virulence factors enhancing fungal colonization and are produced by mammalian and lower eukaryotes, such as yeasts and other fungi (Candida albicans, Histoplasma capsulatum and Cryptococcus neoformans). C. albicans produces prostaglandins (PG), Leukotrienes (LT) and Resolvins (Rvs), whereas the first two have been well documented in Cryptococcus sp. and H. capsulatum. In this review, we cover the eicosanoids produced by the host and fungi during fungal infections. These fungal-derived PGs have immunomodulatory functions analogous to their mammalian counterparts. Prostaglandin E2 (PGE2) protects C. albicans and C. parapsilosis cells from the phagocytic and killing activity of macrophages. H. capsulatum PGs augment the fungal burden and host mortality rates in histoplasmosis. However, PGD2 potentiates the effects and production of LTB4, which is a very potent neutrophil chemoattractant that enhances host responses. Altogether, these data suggest that eicosanoids, mainly PGE2, may serve as a new potential target to combat diverse fungal infections.

9 November 2016 in Scientific Reports
Verified
Journal Article
Open access
HMHugo Macedo-Ramos
Hugo Macedo-Ramos
SMSusana Mendoza
Susana Mendoza
Rafael MarianteRafael Mariante
Rafael Mariante
EGErick V. Guimarães
Erick V. Guimarães
LQLucas C. Quadros-De-Souza
Lucas C. Quadros-De-Souza
WBWagner Baetas-Da-Cruz
Wagner Baetas-Da-Cruz
Olfactory ensheathing cells (OECs) are a type of specialized glial cell currently considered as having a double function in the nervous system: one regenerative, and another immune. Streptococcus pneumoniae is a major agent of severe infections in humans, including meningitis. It is commonly found in the nasopharynx of asymptomatic carriers, and, under certain still unknown conditions, can invade the brain. We evaluated whether pneumococcal cells recovered from lysed OECs and microglia are able to survive by manipulating the host cell activation. An intracellular-survival assay of S. pneumoniae in OECs showed a significant number of bacterial CFU recovered after 3 h of infection. In contrast, microglia assays resulted in a reduced number of CFU. Electron-microscopy analysis revealed a large number of pneumococci with apparently intact morphology. However, microglia cells showed endocytic vesicles containing only bacterial cell debris. Infection of OEC cultures resulted in continuous NF-κB activation. The IFN-γ-induced increase of iNOS expression was reversed in infected OECs. OECs are susceptible to S. pneumoniae infection, which can suppress their cytotoxic mechanisms in order to survive. We suggest that, in contrast to microglia, OECs might serve as safe targets for pneumococci, providing a more stable environment for evasion of the immune system.

1 March 2016 in Neuroscience
Verified
Journal Article
Closed access
SMSusana Mendoza
Susana Mendoza
HMH. Macedo-Ramos
H. Macedo-Ramos
Filipe SantosFilipe Santos
Filipe Santos
LQL.C. Quadros-De-Souza
L.C. Quadros-De-Souza
MPM.M. Paiva
M.M. Paiva
WBW. Baetas-Da-Cruz
W. Baetas-Da-Cruz

27 October 2020 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
CNClaudia Rodríguez-de la Noval
Claudia Rodríguez-de la Noval
SMSusana Mendoza
Susana Mendoza
DGDiego de Souza Gonçalves
Diego de Souza Gonçalves
MFMarina Ferreira
Marina Ferreira
LHLeandro Honorato
Leandro Honorato
AGAllan Guimaraes
Allan Guimaraes
Aspergillosis cases by Aspergillus fumigatus have increased, along with fungal resistance to antifungals, urging the development of new therapies. Passive immunization targeting common fungal antigens, such as chitin and β-glucans, are promising and would eliminate the need of species-level diagnosis, thereby expediting the therapeutic intervention. However, these polysaccharides are poorly immunogenic. To overcome this drawback, we developed the lectin-Fc(IgG) fusion proteins, Dectin1-Fc(IgG2a), Dectin1-Fc(IgG2b) and wheat germ agglutinin (WGA)-Fc(IgG2a), based on their affinity to β-1,3-glucan and chitooligomers, respectively. The WGA-Fc(IgG2a) previously demonstrated antifungal activity against Histoplasma capsulatum, Cryptococcus neoformans and Candida albicans. In the present work, we evaluated the antifungal properties of these lectin-Fc(s) against A. fumigatus. Lectin-Fc(IgG)(s) bound in a dose-dependent manner to germinating conidia and this binding increased upon conidia germination. Both lectin-Fc(IgG)(s) displayed in vitro antifungal effects, such as inhibition of conidia germination, a reduced length of germ tubes and a diminished biofilm formation. Lectin-Fc(IgG)(s) also enhanced complement deposition on conidia and macrophage effector functions, such as increased phagocytosis and killing of fungi. Finally, administration of the Dectin-1-Fc(IgG2b) and WGA-Fc(IgG2a) protected mice infected with A. fumigatus, with a 20% survival and a doubled life-span of the infected mice, which was correlated to a fungal burden reduction in lungs and brains of treated animals. These results confirm the potential of lectin-Fc(IgGs)(s) as a broad-spectrum antifungal therapeutic.

21 October 2026 in Brazilian Journal of Microbiology
Verified
Journal Article
Open access
PDF file
RARodrigo Almeida-Paes
Rodrigo Almeida-Paes
LMLívia Silveira Munhoz
Lívia Silveira Munhoz
SMSusana Mendoza
Susana Mendoza
Vanice Rodrigues PoesterVanice Rodrigues Poester
Vanice Rodrigues Poester
VRVanessa Brito de Souza Rabello
Vanessa Brito de Souza Rabello
CSCecília Bittencourt Severo
Cecília Bittencourt Severo
Sporotrichosis is a subacute to chronic mycosis of major public health relevance in endemic regions, affecting both humans and animals, particularly cats. Rapid and accessible diagnostic tools are urgently needed to improve case detection and disease surveillance. Thus, this study aimed to validate a previously described loop-mediated isothermal amplification (LAMP) assay for the diagnosis of sporotrichosis in clinical samples from humans and cats obtained in two highly endemic areas in Brazil. We conducted an observational study including human patients and cats with suspected sporotrichosis. Analytical sensitivity and specificity were initially assessed using reference strains of Sporothrix spp. The diagnostic performance of the LAMP assay was then evaluated in clinical samples at different incubation times and compared with culture results. Sensitivity, specificity, and additional diagnostic parameters were calculated separately for human and cat cases. The LAMP assay was able to detect the three major Sporothrix species associated with sporotrichosis, with higher analytical sensitivity for S. brasiliensis . However, when applied to human clinical samples, the assay showed limited sensitivity and specificity, particularly at earlier incubation times, resulting in poor overall diagnostic performance. In contrast, performance in cat samples was comparatively higher but still affected by false-positive and false-negative results. Despite promising analytical characteristics and previous success in experimental models, this LAMP protocol demonstrated limited diagnostic utility for human and cat sporotrichosis under real-world clinical conditions, highlighting the need for further optimization and rigorous clinical validation before implementation in routine practice.